Spyglass Capital Management LLC Pacira Bio Sciences, Inc. Transaction History

Spyglass Capital Management LLC

$1.48 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$35.53 - $43.38 $1.34 Million - $1.63 Million	-37,649 Reduced 4.33%	831,037 $33.9 Million
Q4 2022 Feb 14, 2023	SELL	$38.19 - $57.45 $14.7 Million - $22 Million	-383,656 Reduced 30.64%	868,686 $33.5 Million
Q3 2022 Nov 14, 2022	SELL	$51.24 - $58.89 $10.7 Million - $12.3 Million	-208,292 Reduced 14.26%	1,252,342 $66.6 Million
Q2 2022 Aug 15, 2022	SELL	$51.49 - $81.64 $21.1 Million - $33.5 Million	-410,406 Reduced 21.93%	1,460,634 $85.2 Million
Q1 2022 May 16, 2022	SELL	$60.03 - $76.49 $13.9 Million - $17.8 Million	-232,125 Reduced 11.04%	1,871,040 $143 Million
Q4 2021 Feb 14, 2022	SELL	$47.97 - $62.21 $5.18 Million - $6.72 Million	-108,045 Reduced 4.89%	2,103,165 $127 Million
Q3 2021 Nov 15, 2021	BUY	$54.64 - $61.3 $5.11 Million - $5.73 Million	93,537 Added 4.42%	2,211,210 $124 Million
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $8.27 Million - $9.78 Million	139,776 Added 7.07%	2,117,673 $129 Million
Q1 2021 May 17, 2021	BUY	$59.31 - $78.82 $315,944 - $419,874	5,327 Added 0.27%	1,977,897 $139 Million
Q4 2020 Feb 16, 2021	BUY	$50.47 - $66.26 $8.06 Million - $10.6 Million	159,693 Added 8.81%	1,972,570 $118 Million
Q3 2020 Nov 16, 2020	BUY	$51.97 - $63.0 $14.7 Million - $17.8 Million	282,046 Added 18.42%	1,812,877 $109 Million
Q2 2020 Aug 14, 2020	BUY	$30.8 - $52.47 $10.5 Million - $17.9 Million	340,294 Added 28.58%	1,530,831 $80.3 Million
Q1 2020 May 15, 2020	BUY	$28.4 - $50.7 $9.48 Million - $16.9 Million	333,710 Added 38.95%	1,190,537 $39.9 Million
Q4 2019 Feb 14, 2020	BUY	$36.31 - $46.83 $14.5 Million - $18.7 Million	399,577 Added 87.39%	856,827 $38.8 Million
Q3 2019 Nov 14, 2019	BUY	$35.66 - $44.99 $2.77 Million - $3.49 Million	77,641 Added 20.45%	457,250 $17.4 Million
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $5.17 Million - $6.78 Million	141,282 Added 59.28%	379,609 $16.5 Million
Q1 2019 May 15, 2019	BUY	$36.47 - $42.17 $4.31 Million - $4.98 Million	118,170 Added 98.35%	238,327 $9.07 Million
Q4 2018 Feb 14, 2019	BUY	$41.31 - $52.16 $4.96 Million - $6.27 Million	120,157 New	120,157 $5.17 Million

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

Black Rock Inc. New York, NY

8.01M
Shares

$156 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.3M
Shares

$103 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

4.96M
Shares

$96.6 Million
0.18% of portfolio
State Street Corp Boston, MA

2.01M
Shares

$39.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.98M
Shares

$38.5 Million
0.05% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Spyglass Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spyglass Capital Management LLC with notifications on news.

Account